CDH2 and non-small cell lung carcinoma: HJC0152 increased the expression of E‐cadherin but decreased the expression of N‐cadherin and vimentin (Figure 5G and H), suggesting that HJC0152 inhibits acquisition of mesenchymal characteristics in NSCLC cells.